Display Settings:

Format

Send to:

Choose Destination
    Neurodegener Dis. 2010;7(1-3):99-102. Epub 2010 Feb 18.

    Transgenic zebrafish as a novel animal model to study tauopathies and other neurodegenerative disorders in vivo.

    Source

    Deutsches Zentrum für Neurodegenerative Erkrankungen, Standort München, Ludwig-Maximilians University, Munich, Germany.

    Abstract

    Our ageing society is confronted with a dramatic increase in patients suffering from tauopathies such as Alzheimer's disease, frontotemporal dementia and others. Typical neuropathological lesions including tangles composed of hyperphosphorylated tau protein as well as severe neuronal cell death characterize these disorders. No mechanism-based cures are available at present. Genetically modified animals are invaluable models to understand the molecular disease mechanisms and to screen for modifying compounds. We recently introduced tau-transgenic zebrafish as a novel model for tauopathies. Our model allows recapitulating key pathological features of tauopathies within an extremely short time. Moreover, life imaging of tau-dependent neuronal cell death was performed for the very first time. This demonstrated tau-dependent neuronal cell loss independent of tangle formation. Finally, we exemplified that the zebrafish frontotemporal dementia model can be used to screen for drugs that prevent abnormal tau phosphorylation and neuronal cell death.

    Copyright 2010 S. Karger AG, Basel.

    PMID:
    20173336
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for S. Karger AG, Basel, Switzerland

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk